Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

3 months ago 9
Read Entire Article
  1. Homepage
  2. Finance
  3. Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

Related

Annington Funding noteholders reject proposed resolutions

Annington Funding noteholders reject proposed resolutions

43 minutes ago 0
BoE’s Greene sees more rate cuts but fears inflation might fall more slowly

BoE’s Greene sees more rate cuts but fears inflation might f...

43 minutes ago 0
Palestinians cheer as freed prisoners begin to arrive home under ceasefire deal

Palestinians cheer as freed prisoners begin to arrive home u...

43 minutes ago 0

Trending

1. jpm stock
2. vti stock
3. spy
4. colin hanks
5. qqq
6. abat stock
7. tallon griekspoor
8. marc maron
9. burt reynolds
10. avgo stock

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

8 months ago 580
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

6 months ago 367
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

9 months ago 262
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

7 months ago 252
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

7 months ago 225
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved